ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 285706 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 285706; 2) Community: the network communities that were significantly associated with the response to NSC 285706; 3) Molecule: the relationships between components within communities and NSC 285706; 4) MDR: the compounds that were significantly associated with the NSC 285706.

NSC Compound Enrichment Correlation
NSC 730460 16-[4-{(3-Imidazol-1-yl)propoxy}-3-methoxybenzylidene]-3b-py rrolidino-5-androsten-17b-YL acetate 0.0131142867047949 0.38972881
NSC 746248 Null 0.0131142867047949 0.2309424
NSC 750035 Null 0.0131142867047949 0.57347871
NSC 102817 Germacra-1(10),11(13)-diene-12,14-dioic acid, 4,5.alpha.-epoxy-2.beta.,6.alpha.,8.alpha.-trihydroxy-, 12,6:14,2-dilactone, 3-methylcrotonate (8CI) 0.0133299224082802 0.83400177
NSC 269599 Stannane, chlorohydroxydiphenyl- 0.0133299224082802 0.65989929
NSC 328130 Null 0.0133299224082803 0.26358427
NSC 363812 Tetraplatin 0.0133299224082803 0.47068346
NSC 36437 14-Oxabicyclo[11.3.1]heptadeca-4,8-dien-15-one, 2-(acetyloxy)-12-hydroxy-4,8,12-trimethyl-16-methylene-, [1S(1R*,2R*,4Z,8Z,12S*,13R*)]- (9CI) 0.0133299224082803 0.71926895
NSC 39135 Null 0.0133299224082803 0.47556772
NSC 39202 Cyclohexanone, 2,6-bis(piperidinomethyl)- 0.0133299224082803 0.73183818
Total:121  Current:41    [First] [Prev] [Next] [Last]